Financhill
Sell
35

AMPH Quote, Financials, Valuation and Earnings

Last price:
$27.28
Seasonality move :
7.48%
Day range:
$27.22 - $27.81
52-week range:
$25.89 - $53.96
Dividend yield:
0%
P/E ratio:
8.94x
P/S ratio:
1.95x
P/B ratio:
1.78x
Volume:
602.5K
Avg. volume:
594.2K
1-year change:
-36.15%
Market cap:
$1.3B
Revenue:
$732M
EPS (TTM):
$3.06

AMPH Analysts' Consensus Rating

The 5 analysts providing 12-month price projections for Amphastar Pharmaceuticals shares anticipate an average target of $39.80, ranging from a low estimate of $36.00 to a high estimate of $45.00. This average target implies a growth of 45.47% compared to the current stock price of $27.36.

Consensus Price Target

$39.80

Highest Price Target

$45.00

Lowest Price Target

$36.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 0 2 2

Hold 0 3 3

Sell 0 0 0
Consensus -- Hold Hold

AMPH Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Alphabet Stock No Longer a Good Bet?
Is Alphabet Stock No Longer a Good Bet?

Alphabet tripled its price per share over the past 5…

Pepsi Vs Coke Stock: Which Is Best?
Pepsi Vs Coke Stock: Which Is Best?

Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…

Is CyberArk The Next Big Cybersecurity Stock?
Is CyberArk The Next Big Cybersecurity Stock?

CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Sell
48
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Sell
49
SRPT alert for Mar 19

Sarepta Therapeutics [SRPT] is up 8.8% over the past day.

Sell
46
CVNA alert for Mar 19

Carvana [CVNA] is up 4.99% over the past day.

Buy
93
ESLT alert for Mar 19

Elbit Systems [ESLT] is up 0.6% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock